Oskar Hemmingsson

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault et al. · Nature · 2014 · 352 citations

Oncology, Anti-mek Cancer Therapies, Medicine +9

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 174 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +6

Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

David J. Hughes, Talita Duarte‐Salles, Sandra Hybsier et al. · American Journal of Clinical Nutrition · 2016 · 90 citations · Full text

Nutrition, European Prospective Investigation, Cancer Epidemiology +12

Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study

Sebastian E. Baumeister, Sabrina Schlesinger, Krasimira Aleksandrova et al. · Journal of Hepatology · 2018 · 88 citations · Full text

Physical Activity, Physical Activity Epidemiology, Cancer Epidemiology +8

High tie in anterior resection for rectal cancer confers no increased risk of anastomotic leakage

Martin Rutegård, Oskar Hemmingsson, Peter Matthiessen · British journal of surgery · 2011 · 87 citations